AbbVie Showcases New Analyses and Real-World Data Across Multiple Immune-Mediated Skin Diseases at the European Academy of Dermatology and Venereology (EADV) 2022 Congress
Analyses highlight long-term efficacy and safety results, including real-world data, from studies of SKYRIZI® (risankizumab) in moderate to severe...
United States Chiedzo Mpofu Global Medical Affairs European Academy Of Dermatology Epidemiologic Survey On Prevalence Of Genital Psoriasis Boehringer Ingelheim
Source: businessinsider.com